Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지

남자 중학생에서 비만과 high sensitiviy C-reactive protein의 관계

Serum high sensitivity C-reactive protein levels in obese middle school boys

  • 정재호 (건양대학교 의과대학 소아과학교실) ;
  • 임재우 (건양대학교 의과대학 소아과학교실) ;
  • 천은정 (건양대학교 의과대학 소아과학교실) ;
  • 고경옥 (건양대학교 의과대학 소아과학교실) ;
  • 이영혁 (건양대학교 의과대학 소아과학교실)
  • Jeong, Jae-Ho (Department of Pediatrics, College of Medicine, Konyang University) ;
  • Lim, Jae-Woo (Department of Pediatrics, College of Medicine, Konyang University) ;
  • Cheon, Eun-Jeong (Department of Pediatrics, College of Medicine, Konyang University) ;
  • Ko, Kyong-Og (Department of Pediatrics, College of Medicine, Konyang University) ;
  • Lee, Young-Hyuk (Department of Pediatrics, College of Medicine, Konyang University)
  • 투고 : 2006.01.16
  • 심사 : 2006.02.28
  • 발행 : 2006.06.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목 적 : 소아기의 비만은 성인기의 비만여부와 상관없이 대사증후군과 심근경색증의 유병률을 높이는 것으로 알려져 있으며 또한, 직접적인 원인으로 작용할 수 있다고 보고되었다. 그리고, hs-CRP은 장래의 심근경색을 예측할 수 있는 인자이며 특히 비만시에 유의하게 증가되는 것으로 보여 성인에서는 임상적으로 유용하게 쓰이기 시작하였으나, 소아에서의 연구는 미흡한 실정이다. 저자는 소아 비만에서의 hs-CRP의 증가에 대해 조사하고자 하였다. 방 법 : 14세의 소년들을 28명의 비만아군(BMI $29.61{\pm}3.29kg/m^2$)과 93명의 대조군(BMI $18.99{\pm}2.21kg/m^2$)으로 선정하여 연구를 시행하였다. 혈중 CRP 농도는 the high sensitive latex turbidimetric immunoassay를 사용하여 측정하였으며 급성 감염의 영향을 배제하기 위해 측정값이 0.3 mg/dL 미만인 경우만을 실험대상으로 채택하였다. 비만아군과 대조군에 대해서 각각의 hs-CRP의 분포를 알아보았으며 hs-CRP와 BMI, 혈압, 혈중 지질 농도의 연관성에 대해 분석하였다. 결 과 : hs-CRP 농도는 비만아군이 대조군에 비해 통계학적으로 유의하게 높은 측정값을 보였다($0.104{\pm}0.075$ vs. $0.054{\pm}0.005mg/dL$). 비만아군은 대조군에 비해 BMI, 수축기혈압, 이완기혈압, apolipoprotein B, 죽종형성지수와 triglyceride에서 높은 결과치를 나타내었다. 단순회귀분석상에서 hs-CRP는 BMI, 이완기혈압, apolipoprotein E, 죽종형성지수, TG와 통계학적으로 유의한 연관성을 나타내었으나, 다중회귀분석상에서는 BMI와 apolipoprotein E만이 강력한 연관성을 보여주었다. 결 론 : 비만아군은 대조군에 비해 혈중 hs-CRP가 높게 나타났으며 더불어 혈압의 상승과 지질대사이상을 동반하는 경향이 증가함을 보여주었다. 그리고, hs-CRP는 BMI와 apolipoprotein E와 강력한 연관성을 나타내었다. 이 결과들은 비만과 관련된 대사증후군이 소아시기에 이미 시작될 수 있음을 시사하는 것으로 볼 수 있다.

Purpose : High-Sensitivity C-reactive protein(hs-CRP) has been recognized as a very useful and sensitive predictor of the future risk of myocardial infarction. But the clinical significance of hs-CRP in children remains uncertain. To confirm the existence of obesity-induced vascular inflammation and the association between metabolic syndromes and elevation of CRP in children, we investigated the relationship among CRP, obesity, blood pressure(BP), and serum lipids in schoolboys. Methods : Twenty-eight obese(BMI $29.61{\pm}3.29kg/m^2$) and 93 non-obese(BMI $18.99{\pm}2.21kg/m^2$) boys aged 14 years were examined. Serum CRP levels was measured by the high sensitive latex turbidimetric immunoassay and subjects with CRP levels below 0.3 mg/dL were adopted to avoid the influence of acute infection. Results : Obese children had significantly higher hs-CRP levels than their non-obese group($0.104{\pm}0.075$ vs. $0.054{\pm}0.005mg/dL$). In the obese group, BMI, systolic blood pressure, diastolic blood pressure, apolipoprotein B, atherogenic index, and triglyceride were significantly higher than in nonobese. The BMI, diastolic blood pressure, apolipoprotein E, atherognic index, and triglyceride showed positive correlation with log CRP by simple regression. Multiple regression analysis indicated that BMI and apolipoprotein E were strongly related to CRP. Conclusion : This study revealed that obese children tended to have higher levels of serum hsCRP, BP elevation and dyslipidemia than the control group and that BMI and apolipoprotein E were strongly related to CRP. These results indicate that obesity related metabolic syndrome can be developed in children.

키워드

참고문헌

  1. Moon HY, Hong SJ, Suh SJ. The prevalence of obesity in children and adolescents. J Korean Nutrition Society 1992; 25:413-8
  2. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999;83:25F-9F
  3. Insomma B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24: 683-9 https://doi.org/10.2337/diacare.24.4.683
  4. Epstein LH, Wing RR, Valoski A. Childhood obesity. Pediatr Clin North Am 1985;32:368-78
  5. Kim MH, Kim TW, Hong YJ, Son BK, Bae SW, Jang KJ. The prevalence of obesity and underweight in adolescents in Incheon area and the relationship between serum cholesterol level and obesity. J Korean Pediatr Soc 2002;45:174-82
  6. Ridker PM. High-sensitivity C-reactive protein : potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-8 https://doi.org/10.1161/01.CIR.103.13.1813
  7. Danesh J, Collins R, Appleby P. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. JAMA 1998;279:1477-82 https://doi.org/10.1001/jama.279.18.1477
  8. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium- dependent dilatation in human veins in vivo. Circulation 1997;96:3042-7 https://doi.org/10.1161/01.CIR.96.9.3042
  9. Pasceri V, Willerson J, Yeh E. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2002;102:2165-8
  10. Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS. Endothelial dysfunction : cause of the insulin resistance syndrome. Diabetes 1997;46:S9-13 https://doi.org/10.2337/diab.46.2.S9
  11. Doviasova M. Atherogenic index of plasma [log(triglycerides/ HDL-cholesterol)] : theoretical and practical implications. Clin Chem 2004;50:1113-5 https://doi.org/10.1373/clinchem.2004.033175
  12. Shine B, de Beer FC, Pepys MB. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta 1981; 117:13-23 https://doi.org/10.1016/0009-8981(81)90005-X
  13. Lee DH, The incidence of complications in severely obese children. J Korean Pediatr Soc 1991;34:445-53
  14. Lee JB, Lee JO, Kim SW, Kang JH, Yang YJ. The prevalence and risk factors of childhood obesity in elementary student in Seoul. J Korean Acad Fam Med 2000;21:866-75
  15. Knerr I. Obesity and the metabolic syndrome in children and adolescents. MMW Fortschr Med 2004;146:41-3
  16. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004;89:2583-9 https://doi.org/10.1210/jc.2004-0535
  17. Gunnell Dj, Frankel SJ, Nanchahal K, Peters TJ, Davey Smith G. Childhood obesity and adult cardiovascular mortality : a 57-year follow-up study based on the Boyd Orr cohort. Am J Clin Nutr 1998;67:1111-8 https://doi.org/10.1093/ajcn/67.6.1111
  18. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescent : a follow-up of the Harvard Growth Study of 1922 to 1935. N Eng J Med 1992;327:1350-5 https://doi.org/10.1056/NEJM199211053271904
  19. Park SO. Drug approach for reducing inflammation in obesity. J Korean Soc Study Obesity 2003;5:201-9
  20. Kroop IG, Shackman NH. The C-reactive protein determination as an index of myocardial necrosis in coronary artery disease. Am J Med 1957;22:90-8 https://doi.org/10.1016/0002-9343(57)90340-6
  21. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9 https://doi.org/10.1056/NEJM199704033361401
  22. Ridker PM, Glynn RJ, Hennekens Ch. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998;97:2007-11 https://doi.org/10.1161/01.CIR.97.20.2007
  23. Rifai N, Ridker PM. High-sensitivity C-reactive protein : a novel and promising marker of coronary heart disease. Clin Chem 2001;47:403-11
  24. Haverkate F, Thomson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997;349:462-6 https://doi.org/10.1016/S0140-6736(96)07591-5
  25. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercelloti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-20
  26. Lemieux I, Pascot A, Prud'homme D, Almeras N, Bogaty P, Nadeau A, et al. Elevated C-reactive protein : another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001;21:961-7 https://doi.org/10.1161/01.ATV.21.6.961
  27. Dobiasova M, Frohlich J. The plasma parameter log(TG/ HDL-C) as an atherogenic index : correlation with lipoprotein particle size and esterification rate in apoB-lipoproteindepleted plasma(FERHDL). Clin Biochem 2001;34:583-8 https://doi.org/10.1016/S0009-9120(01)00263-6
  28. Miller GJ, Miller NF. Plasma high density lipoprotein concentration and development of ischemic heart disease. Lancet 1975;1:16-9 https://doi.org/10.1016/S0140-6736(02)95332-8
  29. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP, Bingham A, et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. Arterioscler Thromb 1994;13:1412-9
  30. Wang XL, McCredie RM, Wilcken DE. Polymorphism of the apolipoprotein E gene and severity of coronary disease defined by angiography. Arterioscler Thromb Vasc Biol 1995;15:1030-9 https://doi.org/10.1161/01.ATV.15.8.1030
  31. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, et al. Genetic associations with human longevity at the apo E ACE loci. Nat Genet 1994; 6:29-32 https://doi.org/10.1038/ng0194-29
  32. Lenzen HJ, Assmann G, Buchwalsky R, Schulte H. Association of Apolipoprotein E polymorphism, low-density-lipoprotein cholesterol, and coronary disease. Clin Chem 1986; 32:778-81